Nausea and other digestive symptoms are commonly reported with GLP-1 medications, particularly when starting treatment or increasing the dose
Those with a history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or pancreatitis should explore alternative options with their provider
Um, nor and I felt like I was training at the same level that I had been training at
Finally, a systematic review and meta-analysis of randomized controlled trials has shown that the use of DPP-4 inhibitors leads to elevated plasma concentrations of adiponectin [95]
[1] The more advanced regulatory activity belongs to the combination product CagriSema (cagrilintide plus semaglutide), which reached Phase 3 and for which a New Drug Application was reported to have been filed with the FDA in late 2025
Most parents are confused by side effects versus adjustment reactions that goes along with the use of nutraceuticals and lack the needed background to have confidence their child is a ship sailing in the right direction. The end result being that too many unneeded supplements are given in happenstance fashion or the strategy is abandoned altogether and no improvements are realized
![Mechanism of action of GLP-1 [25]](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
